Slovénie -
slovène -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
trialdecal 70 mg tablete + 500 mg/800 i.e. filmsko obložene tablete
meda ab - alendronska kislina - tableta - alendronska kislina 70 mg / 1 tableta - alendronska kislina, kalcij in holekalciferol, zaporedni
Slovénie -
slovène -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
prarecole 10 mg gastrorezistentne tablete
gastrorezistentna tableta - rabeprazol
Slovénie -
slovène -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
prarecole 20 mg gastrorezistentne tablete
gastrorezistentna tableta - rabeprazol
Slovénie -
slovène -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
prarecole 20 mg gastrorezistentne tablete
gastrorezistentna tableta - rabeprazol
Slovénie -
slovène -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
prarecole 10 mg gastrorezistentne tablete
gastrorezistentna tableta - rabeprazol
Union européenne -
slovène -
EMA (European Medicines Agency)
nucala
glaxosmithkline trading services - mepolizumab - astma - zdravila za obstruktivne pljučne bolezni, - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older. chronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate control. eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (egpa). hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.